Leukemia & Lymphoma
Volume 63, 2022 - Issue 13
Open access
2,112
Views
0
CrossRef citations to date
0
Altmetric
Articles
Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study
Ellen Ritchiea Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0001-8150-5542View further author information
, https://orcid.org/0000-0001-8150-5542View further author information
Anas Al-Janadib Spectrum Health, Grand Rapids, MI, USAView further author information
, Craig Kesslerc Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USAView further author information
, Robyn Scherberd Incyte Corporation, Wilmington, DE, USA;e UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USAView further author information
, Tricia Kalafutd Incyte Corporation, Wilmington, DE, USAView further author information
, Haobo Rend Incyte Corporation, Wilmington, DE, USAView further author information
& Ruben Mesae UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USAhttps://orcid.org/0000-0001-5880-7972View further author information
show all
Pages 3138-3153
|
Received 29 Apr 2022, Accepted 07 Aug 2022, Published online: 07 Oct 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.